■中国农村地区基于人群的癌症筛查计划,针对这些地区最常见的三种癌症,包括食道,胃,自2007年以来,中国政府授予了肝癌。在该计划指定的当地医院免费采用了基于问卷调查和HBsAg试纸的癌症风险评估两步设计,并随后对高危人群进行了临床干预。包括高风险率和筛查率在内的参与率对于找到适当的策略以提高对该计划的整体认识很重要。
■来自2010年至2016年癌症筛查计划的数据用于计算更高的比率(高风险人群/招募的参与者)和筛查率(参与者接受筛查/高风险人群)。
■从2010年到2016年,该计划招募了1,637,429名居民,并填写了问卷,350,646(21.4%)用于食道癌,胃癌为273,715(16.7%),肝癌为1,013,068(61.9%)。471,974名参与者被评估为高危人群,包括114,786名(24.3%)食管癌高危人群。161,809(34.3%)胃癌高风险和195,379(41.4%)肝癌高风险,分别。249,185名(52.8%)被评估为高风险的参与者接受了临床筛查。有64,710(26.0%)进行食道癌筛查,71,365(28.6%)用于胃癌筛查,113,110(45.4%)用于肝癌筛查,分别。
■我们的发现将为设计有效的基于人群的筛查策略提供重要参考,以提高未来健康行动计划对筛查的接受度。
UNASSIGNED: A population-based cancer screening program in rural China, targeting three types of cancer that are most prevalent in these areas, including esophageal, stomach, and liver cancer was awarded by the government in China since 2007. A two-step design with cancer risk assessment based on questionnaire interview and HBsAg test strip and subsequent clinical intervention for high-risk populations was adopted with free of charge at the local hospitals designated in the program. The participate rate including high-risk rates and screening rates was important to find appropriate strategies to improve the overall awareness of the program.
UNASSIGNED: Data from the cancer screening program between 2010 and 2016 were used to calculate higher rate (high-risk population/ participants recruited) and screening rate (participants received screening/ high-risk population).
UNASSIGNED: From 2010 to 2016, 1,637,429 residents were recruited in the program and filled the questionnaires, 350,646 (21.4%) for esophagus cancer, 273,715 (16.7%) for stomach cancer and 1,013,068 (61.9%) for liver cancer. 471,974 participants were assessed as high-risk population including 114,786 (24.3%) high risk for esophagus cancer, 161,809 (34.3%) high risk for stomach cancer and 195,379 (41.4%) high risk for liver cancer, respectively. 249,185 (52.8%) participants who were assessed as high risk received clinical screening. There were 64,710 (26.0%) for esophagus cancer screening, 71,365 (28.6%) for stomach cancer screening and 113,110 (45.4%) for liver cancer screening, respectively.
UNASSIGNED: Our findings will provide important references for designing effective population-based screening strategies to enhance the screening acceptance by health action plan in the future.